David Perry (entrepreneur)
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (August 2018) |
David Perry | |
|---|---|
| Nationality | American |
| Education | University of Tulsa Harvard University |
| Occupation | Entrepreneur |
| Employer | Indigo Agriculture |
David Perry was the CEO and Director of Indigo Agriculture (earlier known as Symbiota), an agricultural technology company headquartered in Boston, United States. [1][2] He is a serial entrepreneur in the life sciences industry. He has co-founded Anacor Pharmaceuticals, Chemdex, NexPrise, Virogen and FareWell. He is known to lead successful IPOs while generating returns for investors.[3] In September 2020, he was replaced by Ron Hovsepian, Indigo’s acting chief operating officer. Perry is also leaving the company’s board.[4]
Early life and education
Perry was raised on his family's farm in rural Arkansas. He holds a BS from the University of Tulsa and an MBA from Harvard Business School.[5] He also attended the United States Air Force Academy. He began his career at Exxon, where he managed the operations and maintenance of an oil refinery.
Career
In 1995, while at Harvard Business School, David Perry founded Virogen, a biotechnology company focused on diagnostics.[6]
While at Virogen, he felt that scientists spent a lot of time in procuring life sciences products through conventional catalog ordering. So in 1997, he founded Chemdex, headquartered in California. It is a B2B marketplace focusing on the life-sciences industry and sells laboratory chemicals and other scientific equipments online.[7][8][9] In the same year, he also created the parent company of Chemdex, called Ventro Corporation which was later sold to Nexprise. He served as its CEO and President until November 2001.[10]
In 2002, Perry co-founded Anacor Pharmaceuticals and served as its CEO for twelve years. The biopharmaceutical company is focused on developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. In 2016, the company was acquired by Pfizer for $5.4 billion.[11]
In 2015, Perry co-founded Better Therapeutics (also known as FareWell), a digital therapeutics company focused on preventing and reversing chronic disease through lifestyle changes. He is also on the Board of Directors of the human microbiome company, Evelo Biosciences.
In January 2015, Perry began his now former role as President, Director and CEO of Indigo Agriculture.
Awards and recognitions
- EY Entrepreneur of the Year 2000 – Northern California for Ventro Corporation[12][13]
- 2017 Pioneering Leader Award by Flagship Pioneering[14]
See also
References
- ^ David P. Perry on BloombergBloomberg
- ^ This Startup Wants to Use Bacteria to Revolutionize How Our Food Is ProducedFortune Retrieved 18 February 2016
- ^ David Perry on CrunchbaseCrunchbase
- ^ Rosen, Andy (September 2, 2020) CEO leaves high-flying Boston startup Indigo Ag Boston Globe
- ^ David Perry at HarvardHarvard Business School
- ^ David Perry – Ventro CorporationThe Wall Street Transcript Retrieved 26 June 2000
- ^ Good ChemistryForbes Retrieved 21 February 2000
- ^ Chemdex shines on market debutCNet Retrieved 2 January 2002
- ^ A virtual chemical bazaarForbes Retrieved 6 January 1999
- ^ David PerryCNBC Retrieved 16 August 2018
- ^ Pfizer to buy Anacor in $5.2 billion deal for access to eczema gelReuters Retrieved 16 May 2016
- ^ Company name - Ventro CorporationErnst & Young
- ^ David PerryWorld Economic Forum
- ^ Flagship Pioneering Names David Perry, CEO of Indigo Agriculture, as Recipient of the 2017 Pioneering Leader AwardFlagship Pioneering